Ta
Taiho Pharma
Tokyo JPFounded 19634,000 employees
Private CappharmaPrivateOncology
Platform: Lonsurf FTD/TPI
Market Cap
N/A
All Drugs
2
Clinical Trials
2
Failed / Terminated
1
FDA Approved
0
Drug Pipeline (2 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| Bemasacituzumab | TAI-4247 | Phase 1/2 | 1 | TROP-2 | Hemophilia AOvarian Ca | ||
| TAI-4908 | TAI-4908 | Phase 3 | 1 | Menin | Endometrial CaMDS |
Financial Documents
This is a private company — SEC filings are not available.
Catalyst Events (3)